BRWA
GYRE icon

B. Riley Wealth Advisors’s Gyre Therapeutics GYRE Stock Holding History

B. Riley Wealth Advisors’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-4,667
Closed -$277K – 757
2018
Q4 		$277K Buy
4,667
+1,334
+40% +$98.4K 0.04% 469
2018
Q3 		$270K Hold
3,333
– – 0.03% 532
2018
Q2 		$292K Sell
3,333
-2,267
-40% -$398K 0.04% 474
2018
Q1 		$1.08M Sell
5,600
-2,733
-33% -$510K 0.15% 156
2017
Q4 		$853K Buy
+8,333
New +$425K 0.12% 200

Other funds holding GYRE

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

B. Riley Wealth Advisors's GYRE Position: Q1 2019 in Review

B. Riley Wealth Advisors sold out of Gyre Therapeutics (GYRE) in Q1 2019, closing a stake of 4,667 shares — an estimated $277K sold.

B. Riley Wealth Advisors first reported a position in GYRE in Q4 2017 and held it in 5 quarters. The position peaked at $1.08M in Q1 2018. 63 funds tracked by Wall St. Rank hold GYRE as of Q1 2019.

  • B. Riley Wealth Advisors reported no remaining Gyre Therapeutics position as of Q1 2019 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 4,667 Gyre Therapeutics shares in Q1 2019, an estimated $277K.
  • B. Riley Wealth Advisors first reported a position in Gyre Therapeutics in Q4 2017 and held it in 5 quarters.
  • B. Riley Wealth Advisors's Gyre Therapeutics position peaked at $1.08M in Q1 2018.
  • 63 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q1 2019.

Based on B. Riley Wealth Advisors's 13F filing for Q1 2019, filed 8 May 2019.